NR1H4 and metabolic dysfunction-associated steatohepatitis: Studies using FXR-knockout mice treated with OCA showed increased expression of proteins that regulate generation of urea and glutamine synthesis suggesting that therapeutics such as OCA that activate FXR may promote ammonium clearance in MASH patients [38].